2012, Number 3
<< Back Next >>
Bol Med Hosp Infant Mex 2012; 69 (3)
Quality of life in Mexican children with acute lymphoblastic leukemia affiliated with the Seguro Popular insurance program
Dorantes-Acosta E, Villasís-Keever MÁ, Zapata-Tarrés M, Arias-Gómez J, Escamilla-Núñez A, Miranda-Lora AL, Reyes-López A, Manuell-Lee G, Muñoz-Hernández O, Garduño-Espinosa J
Language: Spanish
References: 42
Page: 242-254
PDF size: 450.15 Kb.
ABSTRACT
Background. Health related quality of life (HRQoL) is a multidimensional construct that integrates the individual perception to the disease, treatment, and performance in physical, psychological and social health areas. The aim of this study was to provide a reliable instrument to measure HRQoL in Mexican children with acute lymphoblastic leukemia (ALL).
Methods. The study was conducted in two phases. In the first phase we conducted a systematic review of the literature until 2011. Studies were selected from Medline. It was found that Pediatric Cancer Quality of Life Inventory (PCQL-3) is one of the most widely used instruments to assess HRQoL in children with ALL; therefore, it was applied to 123 patients treated at the Hospital Infantil de Mexico Federico Gomez and to their parents in the second phase of the study.
Results. From the systematic review, we selected 17 studies of the development of instruments to measure HRQoL in children with ALL, and 15 which described their quality of life. In the 123 patients evaluated, we found that HRQoL was lower among children with high-risk ALL and in those children during the early stages of treatment. It was also found that the most common conditions are nausea and anxiety related to medical procedures. Good agreement (Cronbach α = 0.834) was found in the scores of HRQoL between patients and parents.
Conclusions. HRQoL measurement in children with ALL is a central part of the comprehensive assessment of their treatment and prognosis. The PCQL-3 scale is appropriate for its use in Mexican children.
REFERENCES
Pui CH, Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov 2007;6:149-165. doi:10.1038/nrd2240.
Ribeiro RC, Pui CH. Saving the children—improving childhood cancer treatment in developing countries. N Engl J Med 2005;352:2158-2160.
Metzger ML, Howard SC, Fu LC, Peña A, Stefan R, Hancock ML, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 2003;362:706-708.
Langeveld NE, Stam H, Grootenhuis MA, Last BF. Quality of life in young adult survivors of childhood cancer. Support Care Cancer 2002;10:579-600.
Landolt MA, Vollrath M, Niggli FK, Gnehm HE, Sennhauser FH. Health-related quality of life in children with newly diagnosed cancer: a one-year follow-up study. Health Qual Life Outcomes 2006;4:63-71. doi:10.1186/1477-7525-4-63.
Sung L, Klaassen RJ, Dix D, Pritchard S, Yanofsky R, Dzolganovski B, et al. Identification of paediatric cancer patients with poor quality of life. Br J Cancer 2009;100:82-88.
Varni JW, Burwinkle TM, Lane MM. Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application. Health Qual Life Outcomes 2005;3:34-43. doi:10.1186/1477-7525-3-34.
Sitaresmi MN, Mostert S, Gundy CM, Sutaryo, Veerman JP. Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health Qual Life Outcomes 2008;6:96-102. doi:10.1186/1477-7525-6-96.
Solans M, Pane S, Estrada MD, Serra-Sutton V, Berra S, Herdman M, et al. Health-related quality of life measurement in children and adolescents: a systematic review of generic and disease-specific instruments. Value Health 2008;11:742-764.
Arias-Gómez J, Hernández-Hernández D, Benítez-Aranda H, Villasís-Keever MA, Bernáldez-Ríos R, Martínez-García MC. Un instrumento para medir la calidad de vida por medio del desempeño diario en pacientes pediátricos con leucemia. Gac Med Mex 1996;132:19-28.
Varni JW, Katz ER, Seid M, Quiggins DJ, Friedman-Bender A, Castro CM. The Pediatric Cancer Quality of Life Inventory (PCQL). I. Instrument development‚ descriptive statistics‚ and cross-informant variance. J Behav Med 1998;21:179-204.
Varni JW, Katz ER, Seid M, Quiggins DJ, Friedman-Bender A. The pediatric cancer quality of life inventory-32 (PCQL-32): I. Reliability and validity. Cancer 1998;82:1184-1196.
Varni JW, Limbers CA. The pediatric quality of life inventory: measuring pediatric health-related quality of life from the perspective of children and their parents. Pediatr Clin North Am 2009;56:843-863.
Barr RD, Furlong W, Dawson S, Whitton AC, Strautmanis I, Pai M, et al. An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood. Am J Pediatr Hematol Oncol 1993;15:284-290.
Calaminus G, Weinspach S, Teske C, Göbel U. Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionnaire. Klin Padiatr 2000;212:211-215.
Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 1998;7:399-407.
Ward-Smith P, Hamlin J, Bartholomew J, Stegenga K. Quality of life among adolescents with cancer. J Pediatr Oncol Nurs 2007;24:166-171. doi:10.1177/1043454207299656.
Hutchings HA, Upton P, Cheung WY, Maddocks A, Eiser C, Williams JG, et al. Adaptation of the Manchester-Minneapolis Quality of Life instrument for use in the UK population. Arch Dis Child. 2007;92:855-860.
Goodwin DA, Boggs SR, Graham-Pole J. Development and validation of the Pediatric Oncology Quality of Life Scale. Psychol Assess 1994;6:321-328.
Armstrong FD, Toledano SR, Miloslavich K, Lackman-Zeman L, Levy JD, Gay CL, et al. The Miami pediatric quality of life questionnaire: parent scale. Int J Cancer Suppl 1999;12:11-17.
Watson M, Edwards L, von Essen L, Davidson J, Day R, Pinkerton R. Development of the Royal Marsden Hospital paediatric oncology quality of life questionnaire. Int J Cancer Suppl 1999;12:65-70.
Eiser C, Havermans T, Craft A, Kernahan J. Development of a measure to assess the perceived illness experience after treatment for cancer. Arch Dis Child 1995;72:302-307.
Sawyer M, Antoniou G, Toogood I, Rice M. A comparison of parent and adolescent reports describing the health-related quality of life of adolescents treated for cancer. Int J Cancer Suppl 1999;12:39-45.
Parsons SK, Barlow SE, Levy SL, Supran SE, Kaplan SH. Health-related quality of life in pediatric bone marrow transplant survivors: according to whom? Int J Cancer Suppl 1999;12:46-51.
Phipps S, Dunavant M, Jayawardene D, Srivastiva DK. Assessment of health-related quality of life in acute in-patient settings: use of the BASES instrument in children undergoing bone marrow transplantation. Int J Cancer Suppl 1999;12:18-24.
Seid M, Varni JW, Rode CA, Katz ER. The Pediatric Cancer Quality of Life Inventory: a modular approach to measuring health-related quality of life in children with cancer. Int J Cancer Suppl 1999;12:71-76.
Matthes-Martin S, Lamche M, Ladenstein R, Emminger W, Felsberger C, Topf R, et al. Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis. Bone Marrow Transplant 1999;23:1049-1053.
Yeh CH, Hung LC. Construct validity of newly developed quality of life assessment instrument for child and adolescent cancer patients in Taiwan. Psychooncology 2003;12:345-356.
Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer 1987;60:1651-1656.
Eiser C, Vance YH, Horne B, Glaser A, Galvin H. The value of the PedsQLTM in assessing quality of life in survivors of childhood cancer. Child Care Health Dev 2003;29:95-102.
Meeske K, Katz ER, Palmer SN, Burwinkle T, Varni JW. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer 2004;101:2116-2125.
Eiser C, Vance YH, Glaser A, Galvin H, Horne B, Picton S, et al. Growth hormone treatment and quality of life among survivors of childhood cancer. Horm Res 2005;63:300-304.
Eiser C, Davies H, Jenney M, Stride C, Glaser A. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 2006;46:35-39.
Reinfjell T, Lofstad GE, Veenstra M, Vikan A, Diseth TH. Healthrelated quality of life and intellectual functioning in children in remission from acute lymphoblastic leukaemia. Acta Paediatr 2007;96:1280-1285.
Ramchandren S, Leonard M, Mody RJ, Donohue JE, Moyer J, Hutchinson R, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst 2009;14:184-189.
Pogorzala M, Styczynski J, Kurylak A, Debski R, Wojtkiewicz M, Wysocki M. Health-related quality of life among paediatric survivors of primary brain tumours and acute leukaemia. Qual Life Res 2010;19:191-198.
Hamidah A, Wong CY, Tamil AM, Zarina LA, Zulkifli ZS, Jamal R. Health-related quality of life (HRQOL) among pediatric leukemia patients in Malaysia. Pediatr Blood Cancer 2011;57:105-109. doi:10.1002/pbc.23125.
Gohar SF, Comito M, Price J, Marchese V. Feasibility and parent satisfaction of a physical therapy intervention program for children with acute lymphoblastic leukemia in the first 6 months of medical treatment. Pediatr Blood Cancer 2011;56:799-804. doi:10.1002/pbc.22713.
Peeters J, Meitert J, Paulides M, Wiener A, Beck JD, Calaminus G, et al. Health-related quality of life (HRQL) in ALL patients treated with chemotherapy only: a report from the late effects surveillance system in Germany. Klin Padiatr 2009;221:156-161.
Cádiz V, Urzúa A, Campbell M. Calidad de vida en niños y adolescentes sobrevivientes de leucemia linfoblástica aguda. Rev Chil Pediatr 2011;82:113-121.
Sung L, Yanofsky R, Klaassen RJ, Dix D, Pritchard S, Winick N, et al. Quality of life during active treatment for pediatric acute lymphoblastic leukemia. Int J Cancer 2011;128:1213-1220. doi:10.1002/ijc.25433.
Pui CH, Gajjar AJ, Kane JR, Qaddoumi IA, Pappo AS. Challenging issues in pediatric oncology. Nat Rev Clin Oncol 2011;8:540-549. doi:10.1038/nrclinonc.2011.95.